A decade of discovery and development of new anti-malarial medicines has led to a
renewed focus on malaria elimination and eradication. Changes in the way new anti …

Background Preterm birth (PTB) can be caused by different factors. The factors can be
classified into different categories: socio demographic, obstetric, reproductive health …

This document is a PDF generated from the WHO Guidelines for malaria hosted on the
MAGICapp online platform: https://app. magicapp. org/#/guideline/6287. Each time the …

Background Animal embryotoxicity data, and the scarcity of safety data in human
pregnancies, have prevented artemisinin derivatives from being recommended for malaria …

Introduction: Chemotherapy of malaria has become a rapidly changing field. Less than two
decades ago, treatment regimens were increasingly bound to fail due to emerging drug …

Background Artemisinins, the most effective antimalarials available, are not recommended
for falciparum malaria during the first trimester of pregnancy because of safety concerns …

Over the past 10 years, the available evidence on the treatment of malaria during pregnancy
has increased substantially. Owing to their relative ease of use, good sensitivity and …

Severe malaria in pregnancy is a large contributor to maternal morbidity and mortality.
Intravenous quinine has traditionally been the treatment drug of choice for severe malaria in …

The zoonotic parasite Plasmodium knowlesi has emerged as an important cause of human
malaria in parts of Southeast Asia. The parasite is indistinguishable by microscopy from the …

Introduction: Malaria in pregnancy and postpartum cause maternal mortality and adverse
fetal outcomes. Efficacious and safe antimalarials are needed to treat and prevent such …